Oncology & Genetics
Cepheid is expanding its Oncology portfolio to deliver life-changing technology to physicians and their cancer patients.
Xpert® BCR-ABL Ultra
Sensitive and quantitative monitoring of BCR-ABL mRNA in patients with chronic myelogenous leukemia (CML)
Xpert® BCR-ABL Ultra p190 (RUO)
Quantitative assay for the BCR-ABL minor breakpoint (p190) transcript. For Research Use Only (RUO). Not for use in diagnostic procedures.
Xpert® FII & FV
30-Minute Test for Genetic Risk of Thrombosis